Hemlibra Helps to Prevent Bleeds in Mild, Moderate Hem A, Data Show

Hemlibra Helps to Prevent Bleeds in Mild, Moderate Hem A, Data Show

312905

Hemlibra Helps to Prevent Bleeds in Mild, Moderate Hem A, Data Show

Preventive treatment with Hemlibra (emicizumab) is safe and can effectively prevent bleeds in people with mild or moderate hemophilia A, according to an interim analysis of data from the HAVEN 6 clinical trial. Results will be presented at the annual meeting of the American Society of Hematology (ASH) in December in an oral presentation, titled “Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study.”…

You must be logged in to read/download the full post.